IBRX NASDAQ
ImmunityBio, Inc.
1W: -5.0%
1M: -4.1%
3M: -11.0%
YTD: +283.2%
1Y: +166.9%
3Y: +133.8%
5Y: -48.8%
$7.22
-0.52 (-6.72%)
Weekly Expected Move ±11.1%
$6
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$141M
Revenue
+351.5% YoY
$-855M
Net Income
-108.9% YoY
$-298M
Free Cash Flow
+20.9% YoY
99.5%
Gross Margin
-157.9%
Op. Margin
-1431.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE172.9%
ROA-193.2%
ROIC-152.1%
Valuation
P/E-8.7
P/B-8.5
EV/EBITDA-44.4
Leverage
Debt/Equity-1.76
Current Ratio5.10
Interest Cov.-1.9x
Quality Scores
Piotroski F4/9
Altman Z-6.16
Beneish M-1.41